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Arterial smooth muscle cells (SMCs) play a major role in atherosclerosis and restenosis. Diﬀerential display was used to compare
transcription proﬁles of synthetic SMCs to proliferating rat cultured SMC line. An isolated cDNA band (6A3-5) was shown by
northern (7kb) to be upregulated in the proliferating cell line. A rat tissue northern showed diﬀerential expression of this gene in
diﬀerent tissues. Using 5  RACE and screening of a rat brain library, part of the cDNA was cloned and sequenced (5.4kb). Sequence
searches showed important similarities with a new family of transcription factors, bearing ARID motifs. A polyclonal antibody
was raised and showed a protein band of 175kd, which is localized intracellularly. We also showed that 6A3-5 is upregulated in
dediﬀerentiated SMC (P9) in comparison to contractile SMC ex vivo (P0). This work describes cloning, structural, and functional
characterization of a new early gene involved in SMC phenotype modulation.
INTRODUCTION
Migration and proliferation of smooth muscle cells
(SMCs) into the intima plays a key role in the initiation
and perpetuation of atherosclerotic lesions [1, 2, 3]. In-
deed, arterial SMCs are a major component of atheroscle-
rotic plaques and restenotic vessels. According to Ross
[4], proliferation of SMCs in atherosclerotic lesions is
the result of an excessive inﬂammatory ﬁbroprolifera-
tive response to various forms of insult to the endothe-
lium. In these diseased vessel walls, SMCs undergo a phe-
notypic modulation [5, 6] where they change from a
highly contractile, fully diﬀerentiated, state to a synthetic
and/or proliferating dediﬀerentiated phenotype [4, 7, 8].
Subsequently, SMCs are transformed into foam cells by
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accumulatinglipids[9,10,11].HarvestedSMCs,underin
vitroconditions,progressivelylosetheirhighlycontractile
phenotype to another phenotype that mimics synthetic
SMCs present in diﬀuse intimal thickening [11, 12]. In
long-term cultures, aortic SMCs generate a proliferating
transformed phenotype [13, 14] with similarities to pro-
liferating cells [15].
Diﬀerences have been observed, at the gene and
protein level, between the contractile and the syn-
thetic/proliferating phenotypes. However, at this stage, a
greater understanding of the genes implicated in SMC
phenotypic diﬀerentiation is vital to further understand
the pathogenesis of atherosclerosis [16]. In the present
study, rat SMCs showing synthetic (subcultures at pas-
sage 9) or highly proliferating (spontaneously growing V8
cells) phenotypes were compared with regards to their
gene expression by diﬀerential display [17]. The ratio-
nale for comparing these cell cultures relies on the sim-
ilar changes in SMC phenotypes that occur in the for-
mation and progression of vascular lesions. Results ob-
tained allowed the identiﬁcation of a new transcription
factor gene, bearing an ARID motif (AT-rich interaction
domain), present at high levels in proliferating cultured
SMCs. This gene may play an important role in SMC dif-
ferentiation and proliferation.2005:3 (2005) Cloning of a New Early Gene in Rat SMCs 255
MATERIALS AND METHODS
Surgical procedures and animal care strictly con-
formed to the Guidelines of the National Institute of
Health and Medical Research (decree No 87-848 of 19th
October 1987). Sprague-Dawley rats (species: Rattus rat-
tus, strain: OFA, Iﬀa Credo, France) used in this study
were anesthetized with an intraperitoneal injection of
pentobarbital (0.11mL/100mg body weight).
Cellculture
Primary aortic SMCs were obtained from explants
of medial thoracic aortas from 7 to 8 week-old male
Sprague-Dawley rats (250g) and cultured as previously
described [12, 15]. Cell samples were preserved in liq-
uid nitrogen at passages 2–10 and then every 10 passages.
SMCs at passage 10 were shown to be in a synthetic state.
A spontaneously highly proliferating rat smooth muscle
cell line, V8, has been used in this study. This cell line was
established from aortic media of adult rat and passaged
for over 200 times [15]. In stimulation experiments, PMA
was given at 50ng/mL.
TotalandpolyA+RNApreparation
After cell culturing, cells were washed with Hanks
medium (Sigma, France), and used for RNA preparation.
TotalRNAwasextractedusingtheguanidiumthiocyanate
[18] method. For diﬀerential display analysis, genomic
DNA contamination was removed by DNase I (Message-
Clean, GenHunter, Mass, USA). For cDNA library con-
struction and rapid ampliﬁcation of 5  cDNA ends (5 
RACE), poly(A+) RNA was isolated from total RNA us-
ing oligo dT30 primers (Oligotex mRNA Kit, Qiagen,
France).
Differentialdisplayanalysis
Diﬀerential display was performed as previously de-
scribed [17] (RNAimage, GenHunter). Brieﬂy, (i) reverse
transcription (RT) reaction: 0.2µgo ft o t a lR N Af r o me a c h
sample was reverse transcribed with 100U MMLV re-
verse transcriptase in the presence of 250µMd N T P sa n d
2µM H-T11M (M can be either dA, dG, dC, and H is the
Hind III restriction site). The 20-µLR Tr e a c t i o nw a sr e -
verse transcribed for 1 hour at 37◦C, then the enzyme
is denatured by heating at 75◦C for 5 minutes. (ii) PCR
ampliﬁcation: 2µL of the single-strand (ss) cDNA mix-
ture thus obtained was used for 8 diﬀerent PCR reac-
tions, each containing a diﬀerent arbitrary primer from
the 5  end. The 18-µL PCR mix included 2µM of the H-
T11M primer (same as RT), 2µM of a speciﬁc arbitrary
primer, 25µM dNTPs with 0.25µLo fα-33P dATP (2000
Ci/mmole, Amersham, UK) and 1U of Taq DNA poly-
merase (Perkin Elmer Mass, USA). Thermal cycling am-
pliﬁcation parameters (40 cycles) using GeneAmp PCR
System 9600 (Perkin Elmer) were as follows: 94◦C( 1 5
seconds), 40◦C( 2m i n u t e s ) ,7 2 ◦C (30 seconds), and a ﬁ-
n a l5m i n u t e se x t e n s i o ns t e pa t7 2 ◦C. (iii) Separation by
electrophoresis: only 3.5µL of the PCR products was sep-
arated on a 6% denaturing polyacrylamide gel in TBE
buﬀerafteradditionof2µLloadingdye(95%formamide,
10mM EDTA, pH 8.0, 0.09% xylene cyanole, and 0.09%
bromophenol blue). The gels were run for 4 hours at
1400V, dried without ﬁxation for 2 hours at 80◦C, ex-
posed for 72 hours, and then visualized by autoradiogra-
phy.
Bandrecovery,cloning,andsequencing
The ﬁngerprinting of the ampliﬁed fragments was
common between the two cell types under study. (i) Dif-
ferentially expressed bands (up- or downregulated) were
recovered under sterile conditions by excising the gel slice
from the dried gel using a razor blade. Each gel slice was
placed in 100µL sterile water, boiled for 15 minutes to
solubilize the DNA, and then ethanol precipitated in the
presence of glycogen. The pellet was resuspended in ster-
ile water after ethanol washing. (ii) The reampliﬁcation
is done with 4µL of puriﬁed fragment using the same
primer pair and PCR parameters that gave rise to the
band. (iii) Reampliﬁed DNA fragments were run on a
1.5% agarose gel. Bands that succeeded to be reampli-
ﬁed were cloned into PCR II vector (TA cloning kit, In-
vitrogen, The Netherlands). (iv) For DNA sequencing,
minipreps of plasmidic DNA were carried out [19], fol-
lowed by the dideoxy sequencing method [20]( T 7S e -
quencing Kit, Pharmacia, France).
Bioinformatics
The sequences obtained were compared with known
sequences by similarity searching in the diﬀerent
databases (GenBank, EMBL, EST, STS, etc.) using the
BLAST [21]a n dF A S T A[ 22] programs. The multiple-
sequence alignment was carried out using the Omiga 2.0
Software (Oxford molecular, UK).
Probesandnorthernblot
Total RNA was extracted as above, denatured, sepa-
rated by electrophoresis in formaldehyde-MOPS-agarose
gel and then transferred to a nylon membrane (Hy-
bond, Amersham, UK). After capillary blotting per-
formedovernight,themembranewasbakedfor2hoursat
80◦C. Probes for northern blots were prepared following
the random priming method (High Prime, Boehringer,
Germany), using the PCR ampliﬁed inserts in the
PCR II vector described above, and then puriﬁed us-
ing G-sephadex (Quick Spin Columns, Boehringer).
Prehybridization and hybridization were done accord-
ing to standard protocols [23]. Blots were exposed,
at −70◦C, with intensifying screens against a Ko-
dak ﬁlm for one week. Similar loading of RNA
was assessed by using the actin probe. The follow-
ing primers (Eurogentec, Belgium) were used for the
preparation of cdk2α probe by RT-PCR (see below):
cdk2α up: ACGGAGTGGTGTACAAAGCC, cdk2 down:
GAGTCTCCAGGGAATAGGGC.256 Kazem Zibara et al 2005:3 (2005)
5  rapidampliﬁcationofc-DNAends(5  RACE)
To obtain the upstream 5  region of the new gene,
the 5  RACE technique was carried out basically by ap-
plying the touchdown PCR principle [24] and by using
Marathon cDNA ampliﬁcation and Advantage KlenTaq
polymerase kits (Clontech Calif, USA). (i) In the ﬁrst step,
ss cDNA is synthesized with 1µg of V8 poly(A+) RNA,
using 10µM of the cDNA synthesis primer and MMLV-
RT for 1 hour at 42◦C. DNA synthesis was veriﬁed by
the addition of dNTPs among which one was radiola-
beled α − 32P dCTP (1µCi/µL, NEN, France). (ii) The
second step was the synthesis of ds DNA carried out at
16◦C for 3 hours in an enzyme mixture containing E
coli DNA polymerase I, Rnase H, and Ec o l iDNA lig-
ase. These enzymes allow the synthesis of ds cDNA, RNA
degradation, and the formation of blunt ends, respec-
tively. A 1% agarose gel electrophoresis is done to esti-
mate the quantity and quality of the ds cDNA synthe-
sized. The gel is then dried and put in contact with a Ko-
dak ﬁlm at −70◦C in order to visualize the DNA smear.
(iii) The third step allows us to obtain a library of ds
cDNA, from V8 cells, by ligating an adapter to both ends
of the ds cDNA, using a T4 DNA ligase at 16◦C overnight.
(iv) In the last step, an aliquot of the library is sub-
jected to PCR. The 50-µL PCR reaction contains 10µM
dNTP, 10µM of the adapter primer (complementary to
the cDNA adapter), 5µL of the 50x KlenTaq polymerase,
and 10µM of gene-speciﬁc primer (GSP) complementary
tothe3  diﬀerentiallyexpressedfragment(6A3-5GSP:5 -
GTATTACAGTTTTAGGGAAGTGAATTC-3 ). The mix-
ture was subjected to a PCR step at 94◦C( 1m i n u t e ) ;f o l -
lowed by 33 cycles of 94◦C (30 seconds), 60◦C( 3 0s e c -
onds), and 68◦C (2 minutes and 15 seconds); and a 5
minutes extension step at 72◦C. The ampliﬁed DNA frag-
ments were cloned into the PCR II vector and puriﬁed us-
ing Qiagen Plasmid Midi Kit (Qiagen). The insert DNA is
then sequenced commercially (Genome Express, France).
ScreeningofaratbraincDNAlibrary
A cDNA library originating from the rat brain and
containing hard-to-clone 5  end of long cDNAs was pur-
chased from OriGene Technologies, Md, USA. Screening
was done according to manufacturer’s guidelines. Brieﬂy,
the 96-well master plate was screened by PCR using gene-
speciﬁcprimersthatwereconstructedfromthepreviously
cloned 1.2kb. The following primers were used: 6A3-
5 U18: TTGGGGATCGCAAAAACC, 6A3-5 L21: TAGT-
GAATGGGGCAGAGAAGC. The cycling conditions (40
c y c l e s )w e r ea sf o l l o w s :9 4 ◦C (30 seconds); 94◦C( 1 5s e c -
onds),60◦C(45seconds),72◦C(1minute),andaﬁnalex-
tension step of 5 minutes at 72◦C. After identiﬁcation of
a positive well, a 96-well subplate containing dilutions of
the master positive well is then screened. The same gene-
speciﬁcprimersarethenusedonthesubplateandpositive
wells identiﬁed. Bacteria are then plated and a clone of in-
terest is isolated by ﬁlter hybridization. The positive clone
istheninoculated,puriﬁed,andsequencedaftermidiprep
plasmid preparation.
QuantitativecompetitiveRT-PCR
The quantitative competitive RT-PCR was performed
as described [25, 26]. Brieﬂy, this technique is based on
the addition of a known quantity of a serial dilution of
an exogenous internal recombinant RNA (RcRNA) stan-
dard to a constant quantity of total RNA target RNA sam-
ple. Target and internal standard transcripts are reverse
transcribed and ampliﬁed simultaneously with the same
primers. These primers give rise to 2 bands of diﬀerent
molecular weights but of equal intensities when identical
number of initial RNA molecules are present. (1) In the
ﬁrst step, synthesis of the RcRNA is done in a 4-step pro-
cedure:(i)ampliﬁcationoftheRcDNAusing2Rcprimers
constructed by Oligo 5.0 Primer Analysis Software
(MedProde, Norway). This is done in a 50-µLP C Rr e a c -
tion containing 10mM dNTP, IU Taq polymerase, 100ng
of plasmid cDNA, and 10µMo fe a c hR cp r i m e r .( i i )T h e
PCR product is run on a 1.5% agarose gel in order to
purify the band by Jetsorb (Bioprobe Miss, USA). (iii)
Transcription of the RcRNA (Riboprobe in vitro Tran-
scription, Promega) is done in a 20µL reaction contain-
ing 100mM DTT, 4µL rNTP, 20U RNasine, and 10U of
T7 RNA polymerase for 2 hours at 37◦C. (iv) The product
is treated with 0.5U RQ1 RNase-free DNase for 30 min-
utes at 37◦C, to eliminate plasmidic DNA, and then the
RcRNA concentration is measured by spectrophotome-
try. (2) In the second step, the RT reaction is carried out
in a 10µL total volume with 10mM dNTP, 10mM DTT,
10µM dN6 primers (Boehringer), 10ng of total RNA of
cultured SMCs (P9 or P200), 20U RNasine (Promega,
Wis, USA), 200U MMLV-RT (Gibco, France), and a se-
rial dilution of the RcRNA (10pg/µL, 5pg/µL, 2.5pg/µL,
1pg/µL) for 1 hour at 42◦C. (3) In the third step, the
competitive PCR is performed by using the quantitative
primers with 4xPCR buﬀer (50mM Kcl, 0.04% gelatin)
and 1U of Taq Polymerase. The PCR conditions (30 cy-
cles) are as follows: 95◦C (30 seconds); 94◦C (10 seconds),
60◦C (30 seconds), 72◦C( 2m i n u t e s ) ,a n daﬁ n a le x t e n -
sion step of 5 minutes at 72◦C. (4) In the last step,P C R
products were resolved by gel electrophoresis and rela-
tive density of the signals was determined. The following
primers (Eurogentec) were used:
6A3-5 U18: TTGGGGATCGCAAAAACC,
6A3-5 L21: TAGTGAATGGGGCAGAGAAGC,
6A3-5 U38: TAATACGACTCACTATAGGATTGG-
GGATCGCAAAAACC,
6A3-5 L60: (dT)18TAGTGAATGGGGCAGAGAA-
GCAGACGCAACCAGAGAGTTCAG,
Actin U21: TCGTACCACTGGCATTGTGAT,
Actin L17: GGGCCGGACTCATCGTA,
Actin U41: TAATACGACTCACTATAGGATCGTA-
CCACCACTGGCATTGTGAT,
Actin L57: (dT)18GGGCCGGACTCATCGTAAGA-
CAGCACTGTGTTGGCATAG.2005:3 (2005) Cloning of a New Early Gene in Rat SMCs 257
Westernblot
(i) Protein extraction: cultured cells are washed with
Hanks, trypsinized, and centrifuged at 1200g during 5
minutes. The cell pellet is then lysed in a lysis buﬀer
containing 1% of 10mM aprotinin, 10mM leupeptin,
10mM EDTA, and 1mM phenylmethylsulfonyl ﬂuoride
(inhibitor cocktail, ICN), 25mM Tris pH 7.6, 150mM
NaCl, and 1% Triton X100. Cell lysate is then incubated
during 40 minutes at 4◦C under agitation. When rat tis-
sues are used, they were maintained at −180◦Ci nl i q u i d
nitrogen and pound in a mortar, then homogenized with
aP o l y t r o na t0 ◦C (two 10 seconds burst) in 50mM Tris-
buﬀered saline pH 7.6 containing 1% aprotinin, 2mM
ε-aminocaproic acid, and 0.5mM phenylmethylsulfonyl
ﬂuoride. The homogenate is thencentrifugedat 3000rpm
for 5 minutes to remove the unhomogenized fragment.
Cell- or tissue lysate is then centrifuged at 14000rpm
f o r5m i n u t e st or e m o v ec e l ld e b r i sa n du n l y s e df r a g -
ments, and the supernatant is retained. Quantiﬁcation
of proteins in the supernatant is realized by colorime-
try (BCA kit, Pierce, France). (ii) SDS-PAGE: proteins in
the supernatant are then diluted in Laemmli buﬀer, dena-
tured for 5 minutes at 100◦C, and separated on 7% acry-
lamide SDS-PAGE gels. Migration is done under a con-
stant voltage (100mV) in a migration buﬀer (200mM
glycine,25mMTris,1%SDS).Thegelisthenequilibrated
in the transfer buﬀer (25mM Tris, 192mM glycine, 20%
methanol) for 15 minutes. (iii) Transfer of proteins and
revelation: nitrocellulose membranes (immobilon P, Mil-
lipore) are incubated in methanol for 30 seconds then
rinsed in water and equilibrated in the transfer buﬀer for
15minutes.Theproteinsaretransferredtothemembrane
(100V for 1 hour) then blocked for 2 hours with block-
ing solution containing 3% gelatin and 0.05% Tween 20
in Tris buﬀered saline pH 7.5 (TBS). After washing, the
membrane is incubated overnight at 4◦C with the rab-
bit anti-rat 6A3-5 polyclonal antibody (2µg/mL). Follow-
ing 3 washing steps of 10 minutes in 0.05% TBS-Tween,
a swine anti-rabbit-horse radish peroxidase-conjugated
secondary antibody (DAKO) is incubated during 45 min-
utesatRT.Themembraneisthenwashed(4×10minutes)
in 0.05% TBS-Tween and revealed by a chemiluminescent
technique (ECL Kit, Amersham, UK) according to the
manufacture’s instructions. The ECL ﬁlms are scanned
with Sharp JX-330 scanner (Amersham) and 6A3-5 bands
were quantiﬁed with appropriate software. In parallel,
SDS-PAGE gels, containing identical sample volumes to
those used for the western blot were coomassie stained.
An electrophoretic band (220kd) was scanned and used
as a quantitative control to check for sample loading and
6A3-5 normalization.
FACScananalysis
Conﬂuent SMCs are trypsinized, centrifuged at
1500rpm for 5 minutes at 4◦C ,a n dw a s h e dw i t h1 %
PBS/BSA. Cells are then ﬁxed and permeabilized by 100%
methanol at −20◦C during 10 minutes. After washing
P9 V8 P9 V8
6A3-5
2A3-2
Figure 1. A representative diﬀerential display (DD) analysis
showing up-and downregulated genes. Total RNA was extracted
from synthetic (P9) and proliferating (V8) SMC, then subjected
to DD analysis. Migration of PCR products on a denaturing 6%
polyacrylamide gel for 2 diﬀerent primer pairs is shown. Each
primer pair gives similar RNA ﬁngerprinting between the 2 cell
types. The diﬀerentially expressed bands, having an altered ex-
pression, were cut from the gel and reampliﬁed. Lanes corre-
spond respectively to synthetic (P9) and rapidly proliferating
cells (V8).
with 1% PBS/BSA, the rabbit anti-rat 6A3-5 polyclonal
antibody (5µg/mL) is incubated for 1 hour at 4◦Cw i t h
agitation every 15 minutes. Cells are then washed and
centrifuged for 10 minutes at 1200g. They are then in-
cubated with the secondary antibody (Goat anti-rabbit
FITC-conjugated, DAKO) during 45 minutes at 4◦C. Fol-
lowingwashingsteps,cellsarecentrifugedduring10min-
utes at 1200g. The cell pellet is then suspended, ﬁxed in
1% PBS/formaldehyde, and stocked away from light at
4◦C before analysis by the FACScan apparatus (Becton
Dickinson, France).
RESULTS
Differentialdisplay
Fifty bands were diﬀerentially expressed between syn-
thetic (P9) and highly proliferating cells (V8, Figure 1).
Thirty-six, out of the ﬁfty bands, were selected because
of their high molecular weight. Only 22 bands, out of the
36, were successfully reampliﬁed and cloned into PCR II
plasmid. Reproducible sequence information, containing
ﬂanking sequences corresponding to the particular poly
dT and arbitrary primers used for PCR, was obtained for
only 16 bands.
Sequencingandsimilaritysearches
Sequences from diﬀerent clones were then sent to
GenBank, for identity and similarity search. Some se-
quences (3A1-1, 3A2-7, 4C1-4, 4G3-2, 4A1-4) had 80–
100% similarity with known genes such as: rat glucose-
regulated protein, rat assembly protein, rat glia-derived
nexin, and 2C9 gene. Others (3A1-2, 4A1-7, 6A1-3, 2A3-
5) showed 50–80% similarity with protooncogenes, ki-
nases, and proteases. Four other genes (4G2, 5C1, 2A3-
2, 6A3-5) had no similarities in the databases. Results
of similarity searches in databases are summarized in
Table 1.258 Kazem Zibara et al 2005:3 (2005)
Table 1. Summary of similarities (%) with identiﬁed genes in databases. Results were classiﬁed in diﬀerent categories (80–100%,
50–80%, 30–50%, or no similarity). The band 3A2–4 means that the 5  primer used was arbitrary primer 3 (AP3), and the 3  primer
was dT11A. P9∗ and V8∗ indicate synthetic and proliferating cells, respectively.
Similarity % Band Cell type overexpression Similarity with
80–100%
4G3-2 V8∗ Rat glia-derived nexin
3A2-7 V8 Bombyx nuclear polyhedrosis virus
3A1-1 P9∗ Rat glucose-regulated protein
4A1-4 V8 2C9 gene
4C1-4 V8 Rat assembly protein
Mouse embryonal carcinoma
50–80%
3A1-2 P9 G protein coupled receptor
4A1-7 P9 Human protooncogene tyrosine kinase
Mouse ICAM 1, c-myc
6A1-3 P9 Metalloprotease
Homo sapiens 3  EST
2A3-5 V8 Mouse 3  nerve growth factor
30–50%
2A1-2 V8 Thermo potent virus gene
TSP-4 mRNA
6A2-4 P9 Mouse mammary tumor virus
2A2-1 V8 Protooncogene tyrosine kinase, c-myc
human breast cancer susceptibility virus
No similarity
2A3-2 V8 —
6A3-5 V8 —
5C1 V8 —
4G2 P9 —
Northernblotanalysisandtissuedistribution
of6A3-5gene
Four genes (4G2, 5C1, 2A3-2, 6A3-5), showing no
similarities in the databases, were conﬁrmed by north-
ern blots to be diﬀerentially expressed (Figure 2a). Three
of these genes (5C1, 2A3-2, 6A3-5) were upregulated in
the highly proliferating cell line, compared with synthetic
cells (Figure 2a). One of these genes (2A3-2) was cloned
and characterized in our lab in a previous study [27].
In this work, another gene (6A3-5, 7kb) upregulated in
the highly proliferating cell line, compared with synthetic
cells, was further analyzed. Indeed, a rat multiple-tissue
northern blot, probed by the 6A3-5 cDNA band, showed
this gene (7kb) to be present in diﬀerent organs (Figure
2b). Some tissues such as brain, kidney, and testis showed
a very high expression of the gene. Other tissues such as
skeletal muscles and heart expressed the gene to a lesser
extent. Testis had 3 independent mRNA’s that might come
from diﬀerent polyadenylation sites [28]. The multiple
northern blot shows that 6A3-5 gene is not an artifact in-
duced by cell culturing but is present in vivo in diﬀerent
tissues.
5  RACE,screeningofaratbrainlibrary,cloning,and
sequencingofthe6A3-5cDNA
Part of the 5  coding region of 6A3-5 was obtained
by 5  RACE using a cDNA library that we constructed
from the V8 highly proliferating cells. The size of the
5  RACE-PCR product was 1.2kb while the full length
mRNA size was determined, by northern, to be 7kb. The
5  RACE-PCR product (Figure 3) was ampliﬁed, puriﬁed,
cloned, and sequenced. This original 6A3-5 nucleotide
sequence was then sent to GenBank and to the Euro-
pean Molecular Biology Laboratory (EMBL) to get an ac-
cession number (AJ005202). Gene-speciﬁc primers were
then constructed and used on a cDNA library originating
from the rat brain and containing long cDNAs. Screening
ofthebrainlibraryallowedtheisolationofaspeciﬁcclone
thatwasfullysequenced(5.4kb).Thisclonecontainedthe
previously identiﬁed 1.2kb.
Characteristicsofthe6A3-5cDNAandprotein
The open reading frame of the sequenced part of
the gene (5410bp) was identiﬁed and showed to contain
4708bp running to a TGA stop codon (Figure 4). This se-
quence contained poly-CAG repeats between nucleotides
3896 and 3913. The 5  untranslated region, as well as the
uppermost 5  coding region, has not yet been cloned.
The cDNA contained 681bp in the 3 -untranslated re-
gion with a typical poly-A signal (AATAAA) that was
determined 73bp upstream of the poly-A tail [29]. On
the protein level, 6A3-5 had an ARID domain (187–296),
LXXLL motif (1177–1181), a Q-rich region (1298–1304),
a serine-rich region (112–175), and a phenyl-rich region
(1472–1481) (Figure 5). Analysis of the 6A3-5 protein
fragment revealed the presence of multiple glycosylation
sites, phosphorylation sites, myristyl sites, and amida-
tion sites. The hydropathy analysis data indicated that
there were no signiﬁcant hydrophobic transmembrane
domains.2005:3 (2005) Cloning of a New Early Gene in Rat SMCs 259
P9 V8
4G2
5C1
2A3-2
6A3-5
28S 4.5kb
7kb
1.2kb
(a)
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Rat 6A3-5 7kb
6kb
5kb
(b)
Figure 2. Northern blot analysis of 6A3-5 diﬀerentially displayed cDNA band. (a) Four genes (4G2, 5C1, 2A3-2, 6A3-5), showing
no similarities in the databases, were conﬁrmed by northern blots to be diﬀerentially expressed. The 6A3-5 gene is upregulated in
proliferating (V8) but not synthetic cells (P9). Quantiﬁcation of 6A3-5 signals (n = 3), reported to 28S levels, showed a 3-fold
increase in the V8 compared to the P9 cells. The 6A3-5 mRNA has a size of 7kb as given by northern blot. The internal deposition
control of the same RNA quantity is given by 28S. Lanes P9 and V8 correspond respectively to synthetic and rapidly proliferating cells.
(b) Multiple-tissue northern blot analysis with the 6A3-5 cDNA band in the rat. The blot contained 20µgo ft o t a lR N Af r o mv a r i o u s
rat tissues and was probed with the 6A3-5 cDNA fragment isolated by DD. Transcripts of ∼ 7kb could be observed in all rat tissues
analyzed, but at diﬀerent levels of expression. Indeed, brain, kidney, and testis tissuesexpressed thisgene at very high levels. Two lower
transcripts of ∼ 6a n d∼ 5kb were also observed for testis. Lane T, testis; lane K, kidney; lane Sk, skeletal muscle; lane Li, liver; lane L,
lung; lane S, spleen; lane B, brain; lane H, heart.
Nucleotidesimilaritysearch
DNA FASTA search program was used to search for
sequences showing relationships to rat 6A3-5 (see Table
2). Similarity searches revealed important similarities
mainly with mouse, rat, and human ESTs. The highest
similarities with 6A3-5 were with the following. (1) An
EST (99% identity) coming from rat PC12 cells [30].
This EST clone could not be reproduced by the TIGR260 Kazem Zibara et al 2005:3 (2005)
ΦX174
6A3-5 1.2Kb
Figure 3. 5  RACE-PCR ampliﬁcation. A cDNA library (ob-
tained from V8 proliferating cells) was used along with a primer
coming from the 3  end of the 6A3-5 band. The other primer
in the PCR comes from the adapter that is already ligated to the
cDNA library. The touchdown PCR technique was used during
the5  RACE,whichallowedustoobtainapartofthecDNA.The
size of the 5  RACE-ampliﬁed 6A3-5 fragment is 1.2kb. φX174
is given on the left as a molecular weight marker. The lanes rep-
resent diﬀerent dilutions of the cDNA library.
institute due to contamination problems. (2) A newly
identiﬁed human clone (92% identity, KIAA1235) orig-
inating from a brain library. This partially sequenced
clone (5.3kb) contains an ARID domain (AT-rich in-
teraction domain). It is known that genes of the ARID
family are important for binding to DNA [31, 32]. (3)
A cDNA product (72% identity, b120) whose coding se-
quence was cloned as part of a search for genes con-
taining CAG repeats [33]. (4) p270 cDNA (72% iden-
tity) which is also a transcription factor of the ARID
family. It is interesting to note that b120 sequence ap-
pears to be a portion of p270, but whose coding se-
quencecontainsaframe-shiftthatgivesrisetoatruncated
p270.
Proteinsimilaritysearch
FASTA program identiﬁed several proteins with sta-
tistically signiﬁcant degree of relationship to rat 6A3-5
(Table 3). Proteins with signiﬁcant similarity to r6A3-
5 include the following. (1) A translated human brain
KIAA1235 clone (99% identity). (2) p270, an ARID tran-
scription factor (78% identity) which was ﬁrst identi-
ﬁed through its shared antigenic speciﬁcity with p300
and CREB binding protein (CBP). This protein (p270 or
SWI1) is member of the SWI-SNF complex which is im-
plicated in the regulation of the transcription by modi-
fying the conformation of nucleosomes [34, 35, 36]. (3)
b120 protein (78% identity) which is highly expressed
in skeletal muscles and the brain. It was suggested to be
implicated in lipid metabolism and could be responsible
for Schnyder crystalline corneal dystrophy [37]. (4) Eye-
lid protein (eld, also referred to as OSA) which is an-
other transcription factor of the ARID family. Our pro-
tein sequence had 52% identity with the eld protein. Eye-
lid is an ubiquitous expressed protein involved in em-
bryonic growth, development, and diﬀerentiation of the
eye in the drosophila (segmentation and photoreceptor
diﬀerentiation) [38, 39]. p270 and eyelid are large pro-
teins with high degree of identity. (5) Finally, there were
also interesting similarities to other transcription factors
such as IkB epsilon, human BAT2, and APETALA-1. Se-
quences of KIAA1235, p270, b120, Eld, and Osa genes re-
veal shared motifs that are potentially functional. They
bear a Q-rich region that might be implicated in transac-
tivation functions [40]. They also contain the amino acid
motif LXXLL, which has been shown to be critical for the
binding of a variety of nuclear proteins to nuclear hor-
mone receptors [41]. Finally, they contain an ARID do-
main that is implicated in the binding to the DNA. This
ARID domain on 6A3-5 sequence runs over 105aa and
has 86% similarity with the other members of the ARID
family.
QuantitativeRT-PCRanalysisofthe6A3-5gene
Levels of mRNA expression, in synthetic and highly
proliferating SMCs, were also measured using quanti-
tative competitive RT-PCR. Recombinant and quantiﬁ-
cation primers used are given in the methods section.
The quantitative competitive RT-PCR on the 6A3-5 gene
(Figure 6a) showed its expression to be increased by at
least ﬁve times in the proliferating (7.5–10pg) compared
to synthetic cells (1-2pg). RT-PCR was also done using
an actin control, on P9 and V8 cells. This was consid-
ered as an internal control in order to verify that the same
amounts of RNA would give rise to the same number of
actin molecules in both cell types (Figure 6b). This con-
trolgenewasexpressedatthesamelevelinbothcelltypes.
These results further conﬁrm those observed by north-
ern.
Structuralcharacterizationofthe6A3-5
proteininvitroandinvivo
Polyclonal antibodies were raised by rabbit immu-
nization of speciﬁc peptides from the predicted rat pro-
tein sequence. Antibodies revealed speciﬁcally, by west-
ern blot, a unique band of 175kd in V8 SMCs (Figure
7a). Moreover, the 175kd protein band was also observed
in diﬀerent rat tissues, but at diﬀerent levels of expres-
sion (Figure 7b). It is worth noting that brain tissues ex-
pressed the protein at very high levels. Furthermore, FAC-
Scan analysis revealed the presence of this protein only
when SMCs were permeabilized, but not in intact cells
(Figure7c).Thissuggeststhat6A3-5proteinisnotpresent
on the cell membrane but has an intracellular localiza-
tion.
6A3-5expressionincontractileversus
syntheticSMCs
The implication of 6A3-5 in the phenotypic modu-
lation of SMCs was then investigated. Transcription and
proteinexpressionlevelsof6A3-5weremeasuredafterde-
diﬀerentiation of ex-vivo SMCs from a contractile (pas-
sage0,P0)toaninvitrosyntheticphenotype(9thpassage,
P9). Northern blots showed that 6A3-5 is downregulated
in the contractile quiescent phenotype and upregulated in2005:3 (2005) Cloning of a New Early Gene in Rat SMCs 261
GGCACCAGGC CCACCAATGC CCACTGTGAA CCGCAAGGCC CAGGAAGCTG CCGCGGCTGT 60
GATGCAGGCT GCTGCAAACT CAGCCCAAAG CAGGCAAGGC AGCTTTCCTG GCATGAACCA 120
GAGTGGACTC GTGGCCTCCA GCTCTCCCTA CAGCCAGCCC ATGAACAATA ACTCCAACCT 180
AATGGGGACA CAGGCCCAGC CCTACAGCAT GACACCCACC ATGGTGAACA GCTCTACAGC 240
ATCTATGGGT CTTACAGATA TGATGTCTCC CAGTGAGTCC AAACTGTCCG TGCCTCTTAA 300
AGCAGATGGC AAAGAAGAAG GTGTGCCCCA GCCTGAGAGC AAGTCAAAGG ATAGCTACAG 360
CTCTCAGGGT ATTTCTCAGC CTCCAACTCC AGGCAACCTG CCAGTCCCTT CCCCAATGTC 420
CCCCAGCTCT GCCAGCATCT CCTCCTTTCA CGGAGATGAG AGTGATAGCA TTAGCAGCCC 480
AGGCTGGCCC AAGACTCCAT CAAGCCCTAA GTCCAGCTCC TCTTCCACCA CTGGGGAGAA 540
GATCACAAAA GTGTATGAGC TGGGGACTGA GCCGGAGAGG AAGCTGTGGG TCGACCGCTA 600
CCTGACATTC ATGGAGGAGA GGGGGTCCCC CGTGTCCAGT CTGCCGGCAG TGGGCAAGAA 660
GCCCCTGGAC CTGTTCCGAC TCTATGTGTG CGTCAAAGAG ATCGGAGGCT TGGCGCAGGT 720
TAATAAAAAC AAGAAGTGGC GTGAGCTGGC AACCAACCTG AACGTTGGCA CTTCGAGCAG 780
CGCAGCCAGC TCCCTGAAGA AGCAATATAT TCAGTACCTG TTCGCCTTCG AGTGCAAAAT 840
TGAGCGTGGG GAGGAGCCCC CGCCTGAAGT CTTCAGCACG GGGGATGCGA AGAAGCAGCC 900
CAAGCTCCAG CCGCCATCTC CTGCTAACTC GGGATCCTTA CAAGGTCCAC AGACGCCACA 960
GTCAACTGGC AGCAGTTCCA TGGCAGAGGT TCCCGGTGAC CTGAAGCCAC CAACCCCAGC 1020
CTCCACCCCT CACGGACAGG GGACCCCCAT GCAAAGCGGA AGAAGCAGTA CAGTCAGTGT 1080
GCATGACCCG TTCTCAGACG TGAGTGATTC AGCGTACCCA AAACGGAACT CCATGACTCC 1140
AAACGCCCCA TACCAGCAGG GCATGGGCAT GCCAGACATG ATGGGCAGGA TGCCCTATGA 1200
GCCCAACAAG GACCCTTTCA GTGGAATGAG AAAAGTGCCT GGAAGCAGCG AGCCCTTTAT 1260
GACACAAGGA CAGATGCCCA ACAGCAGTAT GCAGGACATG TACAACCAGA GTCCCTCAGG 1320
TGCCATGTCC AATCTGGGCA TGGGACAGCG GCAGCAATTT CCCTATGGAA CCAGTTATGA 1380
CCGAAGGCAT GAGGCTTACG GGCAGCAGTA CCCAGGCCAA GGCCCTCCCA CAGGACAGCC 1440
ACCGTATGGA GGACACCAGC CTGGCCTGTA CCCACAGCAG CCGAATTACA AACGCCATAT 1500
GGATGGCATG TACGGGCCTC CAGCCAAGCG CCACGAGGGA GACATGTACA ACATGCAGTA 1560
TGGCAGCCAA CAGCAGGAGA TGTATAACCA GTACGGAGGC TCCTACTCTG GCCCGGACAG 1620
AAGGCCCATC CAGGGACAGT ATCCCTACCC CTACAATAGA GAAAGGATGC AGGGCCCAGC 1680
CCAGATGCAA ACACATGGAA TCCCACTCAC AATGATGGGT GGCCCCATGC AGTCATCTTC 1740
CAATGAGGGG CCTCAGCAGA ATATGTGGGC TACACGCAAT GATATGCCTT ATCCCTACCA 1800
GAACAGGCAA GGCCCAGGTG GCCCTGCACA GGCACCCCCT TACCCAGGCA TGAACCGCAC 1860
AGATGATATG ATGGTACCTG ATCAGAGGAT CAATCACGAG AGCCAGTGGC CTTCTCATGT 1920
CAGCCAGCGC CAGCCTTATA TGTCATCATC GGCCTCCATG CAACCCATCA CGCGCCCACC 1980
TCAGTCATCC TACCAGACGC CGCCGTCACT GCCAAACCAC ATCTCCAGGG CACCCAGCCC 2040
TGCCTCCTTC CCGCGCTCCC TGGAGAGCCG CATGTCTCCA AGCAAGTCCC CCTTCCTGCC 2100
TGCCATGAAG ATGCAGAAGG TCATGCCCAC GGTCCCCACA TCCCAGGTCA CCGGACCACC 2160
CCCACAGCCA CCGCCAATCA GAAGGGAGAT TACCTTTCCT CCTGGCTCAG TAGAAGCATC 2220
GCAGCCAGTC CTGAAACAAA GGCGGAAGAT TACCTCAAAA GATATTGTTA CTCCCGAGGC 2280
GTGGCGTGTG ATGATGTCCC TTAAATCCGG TCTGTTGGCT GAGAGCACGT GGGCTTTGGA 2340
CACCATCAAC ATTCTCCTCT ATGATGACAG CACTGTCGCC ACCTTCAATC TTTCCCAGCT 2400
GTCGGGGTTC CTGGAACTAC TAGTGGAGTA CTTCCGAAAG TGCCTAATTG ACATTTTCGG 2460
TATTCTGATG GAATATGAAG TGGGTGACCC CAGCCAAAGG GCGCTTGATC ACCGCACAGG 2520
GAAGAAAGAC GACAGCCAGT CCTCGGAGGA CGACTCTGGG AAAGAAGAAG ATGATGCCGA 2580
GTGTCTGGAG GAGGAGGAGG AGGAGGAGGA AGAGGAGGAG GAGGAAGAGG AGCAAGTCAG 2640
TAAAAAGACA GAGTCAGAGG GCAAGAGCAG CTCTGCCCTA GCTGCTCCAG ACACCACTGC 2700
GGACCCCAAG GAGACGCCGA GGCAGGCCAG TAAGTTTGAC AAGCTGCCCA TAAAGATTGT 2760
CAAGAAGAAC AACCTGTTTG TGGTGGACCG GTCCGACAGG CTGGGTCGGG TTCAAGAGTT 2820
CAACAGCGGG CTCCTCCACT GGCAGCTGGG TGGTGGCGAC ACCACTGAGC ACATCCTCAC 2880
TCACTTCGAG AGCAAGATGG AGATCCCTCC TCGCAGGCGT CCACCTGCGC CTCTCAGCTC 2940
CCACGGGAAG AAGAAAGAGC TGGCAGGCAA GGGCGATTCT GAAGAGCAGC CAGAGAAAAG 3000
CATCATAGCC ACCATTGATG ATGTCCTGTC TGCCCGACCA GGGGCCCTGC CGGAAGACAG 3060
CAACCCCGGA CCCCAAACCG AGAGCGGCAA GTTTCCCTTT GGAATCCAGC AGGCCAAAAG 3120
CCACCGGAAC ATCAGGCTCC TGGAGGACGA GCCCAGGAGC CGAGACGAGA CTCCCCTGTG 3180
CACCATTGCG CACTGGCAGG ACTCCCTGGC CAAACGCTGC ATCTGTGTGT CTAACATCGT 3240
GCGGAGCTTG TCTTTCGTGC CTGGCAACGA CGCAGAGATG TCCAAACATC CGGGCTTGGT 3300
GCTGATCCTA GGAAAGTTGA TTCTGCTGCA TCATGAGCAT CCGGAGAGAA AACGGGCGCC 3360
ACAGACCTAT GAGAAGGAGG AGGATGAGGA CAAGGGGGTG GCCTGCAGCA AAGATGAGTG 3420
GTGGTGGGAC TGCCTCGAGG TCTTGCGGGA TAACACACTG GTCACATTGG CTAACATTTC 3480
CGGGCAGCTA GACTTGTCTG CTTACACAGA GAGCATCTGC TTGCCGATCC TGGACGGCTT 3540
GCTGCACTGG ATGGTGTGCC CGTCTGCAGA GGCACAGGAC CCCTTTCCCA CTGTGGGGCC 3600
CAACTCAGTT CTATCGCCAC AAAGACTTGT GCTGGAGACA CTGTGTAAAC TCAGTATCCA 3660
GGACAACAAT GTGGACCTGA TCTTGGCCAC ACCTCCATTT AGTCGTCAGG AGAAATTTTA 3720
TGCTACATTA GTTAGGTACG TTGGGGATCG CAAAAACCCA GTCTGCCGAG AAATGTCCAT 3780
GGCGCTTTTA TCGAACCTTG CCCAGGGGGA TACACTGGCA GCGAGGGCAA TAGCTGTGCA 3840
GAAAGGAAGC ATTGGGAACT TGATAGGCTT CCTGGAGGAC GGGGTCACGA TGGCGCAGTA 3900
TCAGCAGAGC CAGCATACCC TCATGCACAT GCAGCCCCCG CCTCTGGAAC CCCCCAGTGT 3960
GGACATGATG TGCAGGGCGG CCAAAGCTTT GCTGGCTATG GCTAGAGTGG ATGAGAACCG 4020
CTCGGAGTTC CTTTTGCACG AGGGTCGGTT GCTGGATATC TCGATATCCG CTGTCCTGAA 4080
CTCTCTGGTT GCGTCTGTCA TCTGTGATGT ACTGTTTCAG ATTGGGCAGT TAATGACACC 4140
CGTGAGGGCA CACATGTGTG AGGGAACATT AGAGGGTCAC ATATTGACTG GCTGTTTTCT 4200
GTTCTCGTTT ATCCAATGTA GGAAGAAGGA AAAGAAAAAT CTTTGCTTCT CTGCCCCATT 4260
CACTATTTAC CAATTGGGAA TTAAAGAAAT CATTAATTTG AACAGTTATA AATTAATATT 4320
TGCTGTCTGT GTGTATAAGT ACATCCGTTG GGGGATTTCT GTTTCTTTCT CTTTTTTTAA 4380
CCAAAGTTGC CGTCTAGTGC ATTCACAGGT CACATGTTTT TTTGTTTTTT TCATAATTTT 4440
TTTCATGTTG TATTACAGTT TTAGGGAAGT GAATTCACTT TATAAAGTAA AAAGGTTTGG 4500
CAAAAAAATG CTGATAGGAA AATTTCACCA CACTGAGTCA AAAAAGGTGA AAGGAAAATT 4560
GATCCTTAAA TTGATTTCCT ATGAATTTTA TTCTTCGCAG AATGAAAAAA GCGAAAGTGC 4620
ATCCCATTGC CCAAAGCTCT GTGCAATAGA AACTTCTAGA GATGTAGGTG TAGGGGCTCG 4680
AGGTATGGCA GTCAGCAGTC TGGCCCAGTG ATGCTGTTCT CTCCACAGGA AAGCGGTTGC 4740
ATTAGGCCTC GAGCAAAAAA CCGCACTCTC AGTTAGGGGT GAAAATCCAC TCCTAACCGC 4800
CAACAGCAGG ATTGCTTCCT CACCACGACC GCCATGTCTG CTGCGACTCA GCCTCCACCT 4860
CACAGATCTT CGTGATTCCT TTCATCATTT TTTAAATATT TTTTTTTTAC TGCCTATGGG 4920
CTGTGATGTA TATAGAAGTT GTACATTAAA CATACCCTCA TATTTTTTTC TTTTCTTTTT 4980
TTTTTTTTAG TACAAAGTTT TTAGTTTCTT TTTCATGATG TGGTAACTAC GAAGTGATGG 5040
TAGATTTAAA TAATTTTTTA TTTTTATTTT ATATATTTTT TCATTAGGAC CATATCTCCA 5100
AAAAACAAGA AAAAGAAACA AAAAATTCAA AAAATTAAAA CAAACAAAAA AAGGGGGTAA 5160
TGTACAAGTT TCTGTATGTA TAAAGTCATG CTCTGTTGGG AGGGCAGCTG GTCCCAATTT 5220
GCTTCATGAA TCAAGGTGTG GAAATGGTTG CATACGGATT GATTTAGAAA ATGAATACCA 5280
GTACATACAA AAAAAAAGAA AAAAGAAAAA CCAATAAACT GAAGAAACAC AACTTCAAAG 5340
ATTTTTCTGT GACAAGAATC CGCATTTGTA TTTCAAGATA ATGTAGTTTA AGAAAAAAAA 5400
AAAAAAAAAA 5410
Figure 4. Analysis of the diﬀerent parts of the rat 6A3-5 cDNA. The nucleotide sequence (5410bp) with the poly-A signal (AATAAA)
underlined. The poly-A tail is given at the end of the sequence whereas the stop codon (TGA) is shown in bold (at position 4708). An
example of poly-CAG repeats is given between 3896–3913. The 3 -untranslated region (3 -UTR) is 681bp. The uppermost 5  coding
region, with the initiation codon and the 5 -UTR, has not been cloned yet.
the synthetic phenotype. Indeed, results show that 6A3-
5 mRNA levels are increased by 300% (3-fold increase,
n = 3)insyntheticSMCs(Figures8aand8b).Oneshould
note the presence of α-actin marker in northern blots of
contractile SMCs (P0) and its loss in the synthetic pheno-
type (P9) [16].262 Kazem Zibara et al 2005:3 (2005)
APGPPMPTVN RKAQEAAAAV MQAAANSAQS RQGSFPGMNQ SGLVASSSPY SQPMNNNSNL 60
MGTQAQPYSM TPTMVNSSTA SMGLTDMMSP SESKLSVPLK ADGKEEGVPQ PESKSKDSYS 120
SQGISQPPTP GNLPVPSPMS PSSASISSFH GDESDSISSP GWPKTPSSPK SSSSSTTGEK 180
ITKVYELGTE PERKLWVDRY LTFMEERGSP VSSLPAVGKK PLDLFRLYVC VKEIGGLAQV 240
NKNKKWRELA TNLNVGTSSS AASSLKKQYI QYLFAFECKI ERGEEPPPEV FSTGDAKKQP 300
KLQPPSPANS GSLQGPQTPQ STGSSSMAEV PGDLKPPTPA STPHGQGTPM QSGRSSTVSV 360
HDPFSDVSDS AYPKRNSMTP NAPYQQGMGM PDMMGRMPYE PNKDPFSGMR KVPGSSEPFM 420
TQGQMPNSSM QDMYNQSPSG AMSNLGMGQR QQFPYGTSYD RRHEAYGQQY PGQGPPTGQP 480
PYGGHQPGLY PQQPNYKRHM DGMYGPPAKR HEGDMYNMQY GSQQQEMYNQ YGGSYSGPDR 540
RPIQGQYPYP YNRERMQGPA QMQTHGIPLT MMGGPMQSSS NEGPQQNMWA TRNDMPYPYQ 600
NRQGPGGPAQ APPYPGMNRT DDMMVPDQRI NHESQWPSHV SQRQPYMSSS ASMQPITRPP 660
QSSYQTPPSL PNHISRAPSP ASFPRSLESR MSPSKSPFLP AMKMQKVMPT VPTSQVTGPP 720
PQPPPIRREI TFPPGSVEAS QPVLKQRRKI TSKDIVTPEA WRVMMSLKSG LLAESTWALD 780
TINILLYDDS TVATFNLSQL SGFLELLVEY FRKCLIDIFG ILMEYEVGDP SQRALDHRTG 840
KKDDSQSSED DSGKEEDDAE CLEEEEEEEE EEEEEEEQVS KKTESEGKSS SALAAPDTTA 900
DPKETPRQAS KFDKLPIKIV KKNNLFVVDR SDRLGRVQEF NSGLLHWQLG GGDTTEHILT 960
HFESKMEIPP RRRPPAPLSS HGKKKELAGK GDSEEQPEKS IIATIDDVLS ARPGALPEDS 1020
NPGPQTESGK FPFGIQQAKS HRNIRLLEDE PRSRDETPLC TIAHWQDSLA KRCICVSNIV 1080
RSLSFVPGND AEMSKHPGLV LILGKLILLH HEHPERKRAP QTYEKEEDED KGVACSKDEW 1140
WWDCLEVLRD NTLVTLANIS GQLDLSAYTE SICLPILDGL LHWMVCPSAE AQDPFPTVGP 1200
NSVLSPQRLV LETLCKLSIQ DNNVDLILAT PPFSRQEKFY ATLVRYVGDR KNPVCREMSM 1260
ALLSNLAQGD TLAARAIAVQ KGSIGNLIGF LEDGVTMAQY QQSQHTLMHM QPPPLEPPSV 1320
DMMCRAAKAL LAMARVDENR SEFLLHEGRL LDISISAVLN SLVASVICDV LFQIGQLMTP 1380
VRAHMCEGTL EGHILTGCFL FSFIQCRKKE KKNLCFSAPF TIYQLGIKEI INLNSYKLIF 1440
AVCVYKYIRW GISVSFSFFN QSCRLVHSQV TCFFVFFIIF FMLYYSFREV NSLYKVKRFG 1500
KKMLIGKFHH TESKKVKGKL ILKLISYEFY SSQNEKSESA SHCPKLCAIE TSRDVGVGAR 1560
GMAVSSLAQ  1569
Figure 5.Analysisofthediﬀerentpartsoftherat6A3-5cDNA.Predicted6A3-5ratproteinsequence(1569aa).TheARIDmotif(187–
296) is shown in bold whereas LXXLL motif (1177–1181), serine-rich region (112–175), Q-rich region (1298–1304), and phenyl-rich
region (1472–1481) are underlined.
6A3-5geneexpressionofsyntheticSMCsfollowing
stimulationbyPMAorFCS
Functional characterization of 6A3-5 gene and its im-
plication in SMC proliferation was then studied. North-
ern blots showed that 6A3-5 gene expression is reduced
to a minimum in quiescent and synchronic SMCs after
serum depletion (0 minutes), in comparison to levels of
expression in standard cell culture conditions (Figure 9).
Incontrast,10%FCSinduced6A3-5genetranscriptionto
amaximumafter1hourofstimulation(12-foldincrease).
On the other hand, PMA induced a peak of 6A3-5 after 2
hours of stimulation (4-fold increase). These data indi-
cate that 6A3-5 gene is induced at a very early stage in re-
sponse to stimuli. Moreover, 6A3-5 mRNA levels decrease
after 1–2 hours then increase, after 24 hours, to go back
to its normal level observed prior to serum depletion and
stimulation.
DISCUSSION
Using diﬀerential display, we have identiﬁed for the
ﬁrst time a new 7kb transcription factor gene (6A3-5)
that is overexpressed in proliferating, but not synthetic,
rat smooth muscle cells. Several lines of evidence back
the above statement: (1) diﬀerential display shows an
upregulation of 6A3-5 in proliferating but not synthetic
SMCs. These results were conﬁrmed by northern blot and
quantitativecompetitiveRT-PCR.Moreover,ratmultiple-
tissue northern showed the presence of this 7kb mRNA
in diﬀerent tissues. (2) 5  RACE technique, followed by
screening ofaratbrainlibrary,allowedusto cloneand se-
quence 5.4kb of the cDNA. (3) This new gene shows, on
databasesearch,importantsimilaritiestodiﬀerenthuman
EST clones. Strong similarities were observed with tran-
scription factors of the ARID family (AT-rich interaction
domain). The ARID motif, which runs over 105aa and
which had 86% similarity with other ARID family mem-
bers, has been identiﬁed, sequenced, and localized on our
protein sequence. 6A3-5 also had similarities with func-
tional domains such as the LXXLL motif and a Q-rich
region. (4) A polyclonal antibody, raised against a 6A3-
5 peptide, showed a 175kd unique protein band under in
vitroandinvivoconditions.(5)FACScananalysisshowed
that the protein was only accessible after cell permeabi-
lization. (6) 6A3-5 was upregulated, using northern and
western blots, in dediﬀerentiated secretory SMCs in com-
parison to contractile quiescent phenotype. (7) This new
gene was signiﬁcantly upregulated, in synthetic P9 cells,
1-2 hours following stimulation by PMA or FCS.
Using diﬀerential display, we have identiﬁed a num-
ber of sequences (12) that showed either 80 to 100%, 50
to 80%, or no similarities to known genes. Five genes,
in the 80–100% cluster, showed interesting similarities in
databases. Indeed, the 4G3-2 sequence had a 93% sim-
ilarity with the rat glia-derived nexin (GDN) or pro-
tease nexin I. This gene is implicated in neurogenesis and
neurite growth [42]. In addition, a study showed that
a nexin-derived serine protease (GdNPF) is implicated
in the migration of the neuronal cells [43]. Moreover,
the GDN has similarities [44] with plasminogen activator
inhibitor (PAI), antithrombin III (ATIII), and α-1 pro-
teinase inhibitor. The second interesting sequence, 3A2-
7, had 97% similarity with autographa calcifornica nu-
clear polyhedrosis virus. This viral tyrosine/serine phos-
phatase gene [45] is used for the overexpression of eu-
karyoticgenes[46].Thethirdsequence,3A1-1,hada98%
similarity with the glucose-regulated protein GRP78 and
rat immunoglobulin heavy chain binding protein. It was
demonstrated that GRP78 is upregulated in cells in case
of energy restrains [47]. Since this gene is overexpressed2005:3 (2005) Cloning of a New Early Gene in Rat SMCs 263
Table 2. Similarities of rat 6A3-5 gene with nucleotide sequences in the databases. After comparison to all databases, 6A3-5 had
similarities mainly to human EST clones (established sequence tags). One interesting EST sequence was the rat PC-12 EST clone.
This rat EST sequence could not be obtained and ampliﬁed. Another interesting EST clone was KIAA1235 which is thought to be a
transcription factor expressed in the brain. The corresponding gene was estimated to be of 6.5kb.
Identity % Similarity over (bp) Similarity with Total length (bp)
99% 358 EM EST RS6253 rat PC-12 NGF-treated cDNA (H34625) 358
99% 2843 EM HTG:AC094993 Rattus norvegicus clone 178015
89% 4557 EM HUM:AB033061 Homo sapiens mRNA for KIAA123 5834
92% 1542 EM HUM:AK000921 Homo sapiens cDNA for FLJ10059 1539
89% 2992 EM HTG:AK033272 Mus musculus 15 days embryo 2684
87% 4056 EM HUM:AF521671 Homo sapiens SWI/SNF 7757
88% 3814 EM HUM:AF468300 Homo sapiens BRG1-b 5482
88% 4056 EM HUM:AF259792 Homo sapiens p250R 5123
87% 4077 EM HUM:AF253515 Homo sapiens BAF250 6361
88% 2791 EM MUS:AC084826 genomic sequence 196947
85% 2796 EM HUM:AL591545 human DNA sequence 41211
85% 2796 EM HTG:BX284653 human DNA sequence 520331
94% 1387 EM MUS:AK129314 Mus musculus mRNA 1455
89% 1994 EM NEW:AK030698 Mus musculus 10 day 2243
67% 2680 EM HUM:AF521670 Homo sapiens SWI/SNF 6418
67% 2680 EM HUM:AF265208 Homo sapiens SWI-SNF 6251
67% 2681 EM HUM:AF219114 Homo sapiens chromatin remodeling 6042
67% 2679 EM HUM:AF231056 Homo sapiens BRG1-a 7696
68% 2413 EM HUM:AK074940 Homo sapiens cDNA 2693
68% 2234 EM HUM:AF268913 Homo sapiens OSA1 5120
87% 957 EM HUM:AK025945 Homo sapiens cDNA: FLJ22292 2220
68% 1983 EM HUM:AK027655 Homo sapiens cDNA FLJ14749 2701
68% 2413 EM HUM:AK074940 Homo sapiens cDNA FLJ90459 2693
85% 840 EM EST:AU117440 Homo sapiens cDNA clone 840
92% 742 EM EST:CD630360 FLP Homo sapiens 757
72% 833 EM HUM:AF265208 Homo sapiens SWI SNF Complex 6251
72% 834 EM NEW AF219114 Homo sapiens chromatin remodeling 6042
69% 701 Bovine thigh muscle gene Af045073 1637
57% 729 EM INV Af053091 drosophila melanogaster eyelid gene 10601
93% 504 EM EST AA709949 mouse mammary gland (T92D01.R1) 500
93% 504 EM EST mouse mammary gland 5 cDNA EST Aa709949 504
92% 387 EM EST human neuronal 5 cDNA EST clone Aa243104 387
91% 535 EM EST AI673781 NCI CGAP GAS4 HOMO (TO73A09.X1) 533
91% 469 EM EST AI439094 NCI CGAP KID11 HOMO (TI87A06.X1) 467
91% 384 EM EST human hela cell 5  cDNA EST clone Aa180335 384
91% 251 EM EST human testis I 5  cDNA EST clone Aa383798 251
89% 517 EM EST human fetal lung 5  cDNA EST clone w16714 551
67% 490 EM EST human fetal liver 5  cDNA EST clone N73163 532
in the synthetic cells, it can act as a suppressor of the mi-
gration and proliferation of synthetic cells. The fourth se-
quence, 4A1-4, had 93% homology with 2C9 gene which
is activated after overexpression of c-fos and is implicated
in cellular invasion [48] or metastasis. It is interesting to
note that c-myc and c-fos are upregulated during resteno-
sis, so it is possible that this gene is implicated in cellular
proliferation. The ﬁfth gene, 4C1-4, had a 92% similar-
ity with mouse embryonal carcinoma F9 clone [49]a n d
with rat assembly protein associated with clathrin vesicles
[50]. It is diﬃcult at this stage to identify the relationship
between these genes. However, some of them may act in
concert following SMC stimulation.
The 6A3-5 cDNA band, following identiﬁcation by
diﬀerential display and conﬁrmation by northern blot,
was selected for further study as it was observed to be up-
regulated in the rapidly proliferating SMCs. This gene did
not show, at the initial stage of the study, any signiﬁcant
similarity to known genes. DNA database search showed
that 6A3-5 has signiﬁcant similarities to human, rodent,
and fruit ﬂy ESTs. Interestingly, 6A3-5 shares important
homologies (90–100%) with ESTs originating from hu-
man fetal brain, testis, neuronal cells, and numerous can-
cerous cell line libraries. One of these similarities (99%)
was with an EST present in a rat pheochromocytoma
PC12 cell line [30] that diﬀerentiates into a neuronal264 Kazem Zibara et al 2005:3 (2005)
Table 3. Similarities of rat 6A3-5 to known proteins in the databases. After comparison to all protein databases (SWISSPROT,
TREMBL, PIR, ...), we had only few similarities to known proteins. The best similarities were with a number of transcription factors.
p270 and b120 had 78% identity (83% similarity matching) while eyelid had 52% identity (61% similarity matching) with 6A3–5.
Identity % Similarity over (aa) Similarity with Total length (aa)
57% 1471 SW:SMF1 HUMAN O14497 SWI/SNF-related, p270 1902
30% 1734 SW:OSA DROME Q8IN94 trithorax group protein OSA 2716
27% 454 SW:DRI1 MOUSE Q62431 dead ringer like-1 protein 601
22% 670 SW:DRI DROME Q24573 dead ringer protein 911
26% 527 SW:DRI1 HUMAN Q99856 dead ringer like-1 protein 593
99% 228 Q9ULI5 KIAA1235 protein 1485
99% 228 Q9NWF5 cDNA FLJ10059 FIS, clone HEMBA 1001 412
78% 238 Q9NUD8 DJ50O24.6 (B120, C1ORF4) 1644
50% 221 O61603 drosophila melanogaster eyelid protein 2715
50% 221 Q9VEG7 OSA Protein 2703
23% 839 SW:GLT5 WHEAT P10388 glutenin, high molecular weight 839
29% 441 SW:W146 HUMAN Q9C0J8 WD-repeat protein WDC146 1336
24% 514 SW:CA1A BOVIN P23206 collagen alpha 1(X) chain protein 674
19% 774 SW:FP1 MYTED Q25460 adhesive plaque matrix protein 875
29% 432 SW:SSXT HUMAN Q15532 SSXT protein 418
28% 433 SW:SSXT MOUSE Q62280 SSXT protein (SYT protein) 418
27% 435 SW:CBPA DICDI P35085 Calcium-binding protein 467
26% 437 SW:CBP1 CAEEL P34545 protein cbp-1 2056
34% 119 SW:OSA DROYA Q9NGB4 trithorax group protein OSA 324
22% 524 SW:SN24 HUMAN P51532 possible global transcription activator 1647
21% 1083 SW:PCLO RAT Q9JKS6 Piccolo protein 5085
24% 503 SW:FP1 MYTCO Q25434 adhesive plaque matrix protein 872
22% 829 SW:NCO6 HUMAN Q14686 nuclear receptor coactivator 2063
23% 503 SW:K10 DROME P13468 DNA-binding protein K10 463
27% 284 SW:PRPL HUMAN P10162 salivary proline-rich protein 276
24% 777 SW:CA14 CAEEL P17139 collagen alpha 1(IV) chain p 1758
24% 399 SW:CA1C MOUSE Q60847 collagen alpha 1(XII) chain 3119
23% 923 SW:DRPL HUMAN P54259 atrophin-1 1185
24% 459 SW:BRM DROME P25439 homeotic gene regulator 1638
24% 503 SW:CBP HUMAN Q92793 CREB-binding protein 2442
25% 263 SW:SSB3 CHICK Q98948 single-stranded DNA-binding 368
24% 424 SW:FYB HUMAN O15117 FYN-binding protein 783
26% 447 SW:BCL9 MOUSE Q9D219 B-cell lymphoma 9 protein 449
21% 742 SW:NCO6 MOUSE Q9JL19 nuclear receptor coactivator 2067
29% 311 SW:SM41 HEMPU Q26264 41 kd spicule matrix protein 407
21% 556 SW:HRS DROME Q960X8 hepatocyte growth factor regulator 760
32% 210 P91018 human BAT2 protein 1357
30% 182 G2739158 IkB Epsilon 364
phenotype following stimulation by NGF. Another im-
portant similarity was with an ARID containing human
brain clone called KIAA1235. In addition, ARID-motif
bearing transcription factor genes (human p270, human
b120, and drosophila eld), albeit with lower similarities to
6A3-5, have been obtained in similarity searches. It is of
considerable interest that other transcription factors (IkB
epsilon, human BAT2 and APETALA-1) share some simi-
larities to 6A3-5.
On the other hand, when investigating the protein
database for structural and functional relationships to
6A3-5, we come across a number of proteins having the
new DNA binding motif termed ARID. It is important to
notethatARIDgenesaretranscriptionfactors(activators,
coactivators, or co repressors) strongly implicated in dif-
ferent physiologic processes such as the regulation of cell
growth,development,andtissue-speciﬁcgeneexpression.
The ARID domain, which runs over 105aa and which
had 86% similarity with other ARID family members, has
been identiﬁed, sequenced, and localized on our protein
sequence. The presence of an ARID motif on our pro-
tein signiﬁcantly bolsters the role of 6A3-5 as a poten-
tial transcription factor since ARID domains are known
to be implicated in the binding to DNA. We were particu-
larly interested in the appearance of human p270, human
eyelid, and drosophila eyelid in this list of proteins. p270
is part of the SWI-SNF complex, ﬁrst identiﬁed in yeast
cells, involved in the regulation of a multiple of inducible2005:3 (2005) Cloning of a New Early Gene in Rat SMCs 265
abc d e fg hi a   b  c  d e  f  g  h i 
524bp
378bp
(a)
abc de fa   b  c  d  e  f 
663bp
480bp
(b)
Figure 6. Quantitative competitive PCR on cultured cells. (a) 6A3-5 RT-PCR done on P9 (a, b, c, d, e, f) and V8 cells (a ,b  ,c  ,d  ,e  ,
f ). We have, in P9 cells, 1–2pg of 6A3-5 in 50ng of total RNA whereas it is 7.5–10pg, in V8 cells. Molecular weight diﬀerence between
normal and recombinant 6A3-5 RNAs is 146bp (the competitor RNA is 378bp whereas the normal RNA is 524bp). aa ,b b  ,c c  ,d d  ,
ee , ﬀ ,g g  ,h h  ,i i   = 25, 20, 15, 10, 5, 2, 1, 0.5, and 0.1pg, respectively. (b) Actin RT-PCR. Both P9 and V8 cells have 40pg of actin
in 10ng of total RNA. Molecular weight diﬀerence between normal and recombinant RNAs, used in the quantiﬁcation, is 183bp (the
competitor RNA is 480bp whereas the normal RNA is 663bp). aa ,b b  ,c c  ,d d  ,e e  , ﬀ  = 75, 50, 40, 35, 30, and 20pg, respectively.
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Figure 7. Structural characterization of 6A3-5 protein by western blot and FACScan. (a) Polyclonal antibodies directed against 6A3-5
bound, by western blot, to a unique band migrating with an apparent molecular weight of 175kd. Lane 1, molecular weight markers;
lane 2, V8 SMCs with anti-6A3-5 Ab; lane 3, V8 SMCs with rabbit anti-vWF polyclonal antibody. (b) Western blot analysis of the
6A3-5 protein in diﬀerent rat tissues. A unique band of 175kd, corresponding to the 6A3-5 protein, was observed in all analyzed rat
tissues, but at diﬀerent levels of expression. Sizes of molecular weight markers are shown on the left (in kd). Lane V8, proliferating V8
cells; lane B, brain; lane K, kidney; lane C, cerebellum; lane Sk, skeletal muscles; lane Ag, adrenal gland; lane L, lung; lane AA, aorta
and aortic arch; lane E, eyes; lane T, testis; lane H, heart. The blot contained the following amounts of total protein extracts: lane V8,
30µg; lanes B to L, 50µg; Lanes AA to H, 80µg. (c) FACScan conﬁrmed the speciﬁcity of polyclonal antibodies raised against 6A3-5
protein. In addition, the protein was only labeled by the antibody when SMCs were permeabilized. This suggests that the protein
has an intracellular localization. (A) Permeabilized SMCs with anti-6A3-5 Ab, (B) nonpermeabilized SMCs with anti-6A3-5 Ab, (C)
permeabilized SMCs with anti-PI3Kinase Ab as a positive control. Anti-vWF represents the negative control.266 Kazem Zibara et al 2005:3 (2005)
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Figure 8. Functional characterization of 6A3-5 in vitro.( a )
Levels of 6A3-5 gene transcription were compared, by north-
ern blot, between the contractile (passage 0, P0) and the se-
cretory/synthetic phenotype (9th passage, P9). Northern blots
showed that 6A3-5 mRNA transcription levels are very low in
the contractile phenotype, in comparison to the synthetic one.
The contractile phenotype (P0) and its loss (P9) were character-
ized by the α-actin marker as a positive internal control of the
experiment. The 18S served as a control for loading and quan-
tiﬁcation. (b) Quantiﬁcation of 6A3-5 signals, done on 3 inde-
pendent northern blots, reported to the 18S levels. Results show
that 6A3-5 mRNA levels are increased by 300% (3-fold increase)
in synthetic cells compared to contractile cells. Results are rep-
resented in a quantitative way with the mean +/− SEM.
genes including those required for the mating-type switch
and sucrose fermentation pathways [51, 52, 53]. More
recent studies suggested that SWI-SNF complex, in re-
sponse to control by multiple steroid hormone receptors
[54, 55, 56, 57], also has a more general role in the reg-
ulation of gene expression during cell growth and devel-
opment in all organisms [58, 59]. Moreover, the complex
has a general nucleosome-remodelling activity that can
be upregulated in response to various signals. It is of in-
terest to note that the drosophila eyelid [38] protein is
implicated in embryonic development and is thought to
be a transcription factor acting as an antagonist to the
wingless (Wg) pathway. In fact, target genes in this path-
way are activated in the absence of eyelid and inhibited
in the presence of an excess of the gene. One should note
that the rat homolog to human p270 is not yet known.
Moreover, human and rat homologs to drosophila eyelid
have yet to be identiﬁed. However, 6A3-5 appears to be a
homolog ofthe humanbrainclone (KIAA1235). It is con-
ceivable that both 6A3-5 and KIAA1235 are the homologs
of drosophila eyelid gene. Other proteins with ARID re-
gions, but with no similarities to 6A3-5, include human
and murine bright, drosophila DRI and its human ho-
molog DRILI, the CMV enhancer binding proteins MRF-
1 and MRF-2, retinoblastoma binding proteins (RBP) 1
and 2, PLU-1, and yeast SWI1 [60, 61, 62, 63]. None of
the ARID genes have been reported to be implicated in
diﬀerentiation and proliferation of SMCs. However, 6A3-
5 and ARID nuclear proteins show similar high molecular
weight (> 140kd) and are diﬀerentially expressed in tis-
sues [6, 11, 18, 61].
Northern blot analysis showed substantial levels of
6A3-5 mRNA in brain, kidney, and testis. Moreover, west-
ern blot of 6A3-5 showed a unique band of a molecular
weight of 175kd, present in multiple rat tissues, albeit at
substantially high levels in brain and testis. It is of inter-
est to note that the possible role of 6A3-5 in the brain is
supported by a 99% similarity with a rat cell line (PC12)
sequence that diﬀerentiates into a neuronal phenotype
following stimulation by NGF. Moreover, a human clone
(KIAA1235), bearing an ARID nuclear domain, was iso-
lated in the brain and showed also an important similar-
ity(99%)to6A3-5.Experimentaldataindicatethat6A3-5
may be a transcription factor implicated in the dediﬀer-
entiation and proliferation of SMCs. Indeed, the antibody
directed against 6A3-5 conﬁrmed, by FACScan, that 6A3-
5proteinisnotlocalizedonthemembranebuthasacyto-
plasmic or nuclear localization. Transcription factors are
either permanently present in an inactive form in the nu-
cleus, or translocated from the cytoplasm to the nucleus
in response to a speciﬁc stimulus [64].
We have observed that at every stage when SMCs
change phenotype, this aﬀects the expression of 6A3-
5. Our data suggest that this protein may be a poten-
tial factor involved in the processes of diﬀerentiation and
proliferation of cells. First, the P9-V8 dediﬀerentiation
model (synthetic versus proliferating cells) demonstrates
that 6A3-5 is upregulated in the dediﬀerentiated V8 cells
in comparison to P9 cells. Second, the P0-P9 diﬀerenti-
ation model (contractile versus synthetic cells) demon-
stratesthat6A3-5isupregulatedinthedediﬀerentiatedP9
c e l l si nc o m p a r i s o nt od i ﬀerentiated contractile P0 cells.
These contractile quiescent cells (passage 0), in compari-
son to dediﬀerentiated SMCs (passage 9), show substan-
tially lower mRNAs and protein levels of 6A3-5. Third,
P9 synthetic cells stimulated by FCS or PMA after cell ar-
rest (an in vitro model of cell proliferation) demonstrates2005:3 (2005) Cloning of a New Early Gene in Rat SMCs 267
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Figure 9. Eﬀects of mitogenic agents on transcriptional expression of 6A3-5 and its possible implication in the proliferation of SMCs.
(a) Synthetic SMCs (9th passage) were depleted from serum during 48 hours, then stimulated by mitogens such as 10% FCS or PMA
(50ng/mL). Northern blots showed that 6A3-5 gene is downregulated in depleted SMCs (0 minute) in comparison to nondepleted
and nonstimulated SMCs (NDNS). Moreover, the potent mitogen PMA induced a peak of 6A3-5 transcription levels after 2 hours
of stimulation. However, northern blots showed that 10% FCS induced 6A3-5 gene transcription to a maximum after 1 hour of
stimulation. The 18S served as a control for loading and quantiﬁcation. (b) Quantiﬁcation of 6A3-5 mRNA signals reported to the
18S levels. Results show that 6A3-5 gene expression is overexpressed by at least 400% (4-fold increase) in PMA-stimulated cells, 1–2
hours of stimulation. Stimulation with 10% FCS results in a 12-fold increase of 6A3-5 gene transcription 1 hour only after induction.
that 6A3-5 is upregulated (1–2 hours after stimulation) in
comparison to resting P9 cells. In fact, when dediﬀeren-
tiated SMCs are synchronized in the quiescent G0 phase,
6A3-5 mRNA levels are signiﬁcantly increased (within a
period of 1–2 hours) following stimulation by PMA or
FCS. Induction of SMC diﬀerentiation and proliferation
bymitogenicagentsresultsinaburstof6A3-5mRNAlev-
els at a very early stage.
Modulation of SMC phenotypes are known to induce
the upregulation of a number of genes such as c-myc,
c-myb, c-fos, p65 subunit of NF-kB, ras proteins, Os-
teopontin, mitogen-activated protein (MAP) kinases, an-
giotensin II, and cdk2 kinase [65, 66, 67, 68, 69, 70, 71,
72, 73]. Moreover, some new genes [74, 75, 76, 77, 78]
were recently found to be upregulated in activated pro-
liferating SMCs such as sgk (serum and glucocorticoid-
regulated kinase), type VIII collagen, nucleophosmin (a
nuclear phosphoprotein implicated in the regulation of
cell growth and protein synthesis), and Interferon in-
ducible protein-10 (IP-10).
In conclusion, this work describes the structural
and functional characterization of a new early gene. In
essence, theses results, when taken together, suggest that
the 6A3-5 gene may play a key role in genetic control
of cellular diﬀerentiation and proliferation. The identiﬁ-
cation of 6A3-5 as a member of the emerging family of
ARID proteins suggests that it might function as a coacti-
vator or corepressor. Such activity may take place in com-
bination with nuclear hormone receptors, as implied by
the presence of the LXXLL motif. This takes place before
activation complexes (including coactivators as p300 and
CBP) are formed at speciﬁc promoter sites. Further work
will be needed to delineate the role of this new gene in
vascular lesions. Phenotypic modulation of SMCs from a
contractile into a secretory and proliferate phenotypes is
the result of changes in gene expression of multiple genes
[79]. The 6A3-5 gene, identiﬁed in this study in SMCs,
could conceivably be part of genes involved in modulat-
ing SMC phenotype. Carefully mapping the cascade of
genes implicated in SMC migration and proliferation, in268 Kazem Zibara et al 2005:3 (2005)
atherosclerosis and restenosis, may ultimately allow a bet-
ter understanding of the SMC phenotypic modulation. It
remains to be seen if the role of 6A3-5 in diﬀerentiation is
limited to SMC or is implicated in other cellularor patho-
l o g i c a lm o d e l so fd i ﬀerentiation.
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